Literature DB >> 25377282

Diagnosis of muscle diseases presenting with early respiratory failure.

Gerald Pfeffer1, Marcus Povitz, G John Gibson, Patrick F Chinnery.   

Abstract

Here we describe a clinical approach and differential diagnosis for chronic muscle diseases which include early respiratory failure as a prominent feature in their presentation (i.e. respiratory failure whilst still ambulant). These patients typically present to neurology or respiratory medicine out-patient clinics and a distinct differential diagnosis of neuromuscular aetiologies should be considered. Amyotrophic lateral sclerosis and myasthenia gravis are the important non-muscle diseases to consider, but once these have been excluded there remains a challenging differential diagnosis of muscle conditions, which will be the focus of this review. The key points in the diagnosis of these disorders are being aware of relevant symptoms, which are initially caused by nocturnal hypoventilation or diaphragmatic weakness; and identifying other features which direct further investigation. Important muscle diseases to identify, because their diagnosis has disease-specific management implications, include adult-onset Pompe disease, inflammatory myopathy, and sporadic adult-onset nemaline myopathy. Cases which are due to metabolic myopathy or muscular dystrophy are important to diagnose because of their implications for genetic counselling. Myopathy from sarcoidosis and colchicine each has a single reported case with this presentation, but should be considered because they are treatable. Disorders which have recently had their genetic aetiologies identified include hereditary myopathy with early respiratory failure (due to TTN mutations), the FHL1-related syndromes, and myofibrillar myopathy due to BAG3 mutation. Recently described syndromes include oculopharyngodistal muscular dystrophy that awaits genetic characterisation.

Entities:  

Mesh:

Year:  2014        PMID: 25377282     DOI: 10.1007/s00415-014-7526-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  124 in total

Review 1.  Adult-onset nemaline myopathy: a case report and review of the literature.

Authors:  K A Gyure; R A Prayson; M L Estes
Journal:  Arch Pathol Lab Med       Date:  1997-11       Impact factor: 5.534

Review 2.  The natural course of non-classic Pompe's disease; a review of 225 published cases.

Authors:  Léon P F Winkel; Marloes L C Hagemans; Pieter A van Doorn; M Christa B Loonen; Wim J C Hop; Arnold J J Reuser; Ans T van der Ploeg
Journal:  J Neurol       Date:  2005-08       Impact factor: 4.849

3.  Respiratory failure due to muscle weakness in inflammatory myopathies: maintenance therapy with home mechanical ventilation.

Authors:  A Selva-O'Callaghan; L Sanchez-Sitjes; X Muñoz-Gall; T Mijares-Boeckh-Behrens; R Solans-Laque; J Angel Bosch-Gil; F Morell-Brotad; M Vilardell-Tarrés
Journal:  Rheumatology (Oxford)       Date:  2000-08       Impact factor: 7.580

4.  Desmin integrates the three-dimensional mechanical properties of muscles.

Authors:  A M Boriek; Y Capetanaki; W Hwang; T Officer; M Badshah; J Rodarte; J G Tidball
Journal:  Am J Physiol Cell Physiol       Date:  2001-01       Impact factor: 4.249

5.  High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa.

Authors:  Juna M de Vries; Nadine A M E van der Beek; Marian A Kroos; Lale Ozkan; Pieter A van Doorn; Susan M Richards; Crystal C C Sung; Jan-Dietert C Brugma; Adrienne A M Zandbergen; Ans T van der Ploeg; Arnold J J Reuser
Journal:  Mol Genet Metab       Date:  2010-08-14       Impact factor: 4.797

6.  Lambert-Eaton myasthenic syndrome presenting with severe respiratory failure.

Authors:  M W Nicolle; D J Stewart; H Remtulla; R Chen; C F Bolton
Journal:  Muscle Nerve       Date:  1996-10       Impact factor: 3.217

7.  Respiratory insufficiency as a presenting symptom of LGMD2D in adulthood.

Authors:  M C Walter; G Dekomien; B Schlotter-Weigel; P Reilich; D Pongratz; W Müller-Felber; J T Epplen; A Huebner; H Lochmüller
Journal:  Acta Myol       Date:  2004-05

8.  The angiotensin-converting enzyme insertion/deletion polymorphism modifies the clinical outcome in patients with Pompe disease.

Authors:  Paola de Filippi; Sabrina Ravaglia; Bruno Bembi; Alfredo Costa; Arrigo Moglia; Giovanni Piccolo; Alessandra Repetto; Andrea Dardis; Giuseppe Greco; Giovanni Ciana; Francesco Canevari; Cesare Danesino
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822

9.  Evaluation of cardiac and respiratory involvement in sarcoglycanopathies.

Authors:  L Politano; V Nigro; L Passamano; V Petretta; L I Comi; S Papparella; G Nigro; P F Rambaldi; P Raia; A Pini; M Mora; M A Giugliano; M G Esposito; G Nigro
Journal:  Neuromuscul Disord       Date:  2001-03       Impact factor: 4.296

10.  Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I.

Authors:  Chiara A Boito; Paola Melacini; Andrea Vianello; Paola Prandini; Bruno F Gavassini; Alessia Bagattin; Gabriele Siciliano; Corrado Angelini; Elena Pegoraro
Journal:  Arch Neurol       Date:  2005-12
View more
  12 in total

Review 1.  [Non-cardiac and non-pulmonary causes of dyspnea].

Authors:  S Francke; B Jabs; J Machetanz; F Pabst; B Schubert; S M Schellong
Journal:  Internist (Berl)       Date:  2015-08       Impact factor: 0.743

2.  Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy.

Authors:  Ewen W Sommerville; Yi Shiau Ng; Charlotte L Alston; Cristina Dallabona; Micol Gilberti; Langping He; Charlotte Knowles; Sophie L Chin; Andrew M Schaefer; Gavin Falkous; David Murdoch; Cheryl Longman; Marianne de Visser; Laurence A Bindoff; John M Rawles; John C S Dean; Richard K Petty; Maria E Farrugia; Tobias B Haack; Holger Prokisch; Robert McFarland; Douglass M Turnbull; Claudia Donnini; Robert W Taylor; Gráinne S Gorman
Journal:  JAMA Neurol       Date:  2017-06-01       Impact factor: 18.302

3.  Clinical, pathological, and molecular genetic analysis of 7 Chinese patients with hereditary myopathy with early respiratory failure.

Authors:  Xiaoqing Lv; Bing Zhao; Ling Xu; Wei Jiang; Tingjun Dai; Dandan Zhao; Pengfei Lin; Chuanzhu Yan
Journal:  Neurol Sci       Date:  2021-11-28       Impact factor: 3.830

4.  Predictors of respiratory decline in myotonic dystrophy type 1 (DM1): a longitudinal cohort study.

Authors:  Marco Mazzoli; Alessandra Ariatti; Giancarlo Garuti; Virginia Agnoletto; Riccardo Fantini; Alessandro Marchioni; Giuliana Galassi
Journal:  Acta Neurol Belg       Date:  2020-07-10       Impact factor: 2.396

Review 5.  BAG3: a new player in the heart failure paradigm.

Authors:  Tijana Knezevic; Valerie D Myers; Jennifer Gordon; Douglas G Tilley; Thomas E Sharp; JuFang Wang; Kamel Khalili; Joseph Y Cheung; Arthur M Feldman
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

Review 6.  A comprehensive review of amyotrophic lateral sclerosis.

Authors:  Sara Zarei; Karen Carr; Luz Reiley; Kelvin Diaz; Orleiquis Guerra; Pablo Fernandez Altamirano; Wilfredo Pagani; Daud Lodin; Gloria Orozco; Angel Chinea
Journal:  Surg Neurol Int       Date:  2015-11-16

7.  Making sense of missense variants in TTN-related congenital myopathies.

Authors:  Heinz Jungbluth; Mathias Gautel; Martin Rees; Roksana Nikoopour; Atsushi Fukuzawa; Ay Lin Kho; Miguel A Fernandez-Garcia; Elizabeth Wraige; Istvan Bodi; Charu Deshpande; Özkan Özdemir; Hülya-Sevcan Daimagüler; Mark Pfuhl; Mark Holt; Birgit Brandmeier; Sarah Grover; Joël Fluss; Cheryl Longman; Maria Elena Farrugia; Emma Matthews; Michael Hanna; Francesco Muntoni; Anna Sarkozy; Rahul Phadke; Ros Quinlivan; Emily C Oates; Rolf Schröder; Christian Thiel; Jens Reimann; Nicol Voermans; Corrie Erasmus; Erik-Jan Kamsteeg; Chaminda Konersman; Carla Grosmann; Shane McKee; Sandya Tirupathi; Steven A Moore; Ekkehard Wilichowski; Elke Hobbiebrunken; Gabriele Dekomien; Isabelle Richard; Peter Van den Bergh; Cristina Domínguez-González; Sebahattin Cirak; Ana Ferreiro
Journal:  Acta Neuropathol       Date:  2021-01-15       Impact factor: 17.088

Review 8.  Recent advances in amyotrophic lateral sclerosis.

Authors:  Nilo Riva; Federica Agosta; Christian Lunetta; Massimo Filippi; Angelo Quattrini
Journal:  J Neurol       Date:  2016-03-30       Impact factor: 4.849

9.  TITINdb-a computational tool to assess titin's role as a disease gene.

Authors:  Anna Laddach; Mathias Gautel; Franca Fraternali
Journal:  Bioinformatics       Date:  2017-11-01       Impact factor: 6.937

10.  Identification of novel target genes in human lung tissue involved in chronic obstructive pulmonary disease.

Authors:  Lena Heinbockel; Sebastian Marwitz; Andra B Schromm; Henrik Watz; Christian Kugler; Ole Ammerpohl; Karoline Schnepf; Klaus F Rabe; Daniel Droemann; Torsten Goldmann
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.